Erik Deichmann Heegaard
Plus aucun poste en cours
Fortune : - $ au 31/05/2024
Historique de carrière de Erik Deichmann Heegaard
Anciens postes connus de Erik Deichmann Heegaard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EVAXION BIOTECH A/S | Directeur Technique/Scientifique/R&D | 01/01/2021 | 01/03/2023 |
| NOVO NORDISK A/S | Directeur Technique/Scientifique/R&D | 01/01/2011 | 01/01/2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2015 | - |
Formation de Erik Deichmann Heegaard
| University of Copenhagen | Doctorate Degree |
Statistiques
Internationale
| Danemark | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Bourse
- Insiders
- Erik Deichmann Heegaard
- Expérience
